170 related articles for article (PubMed ID: 32907434)
1. New classes of potent heparanase inhibitors from ligand-based virtual screening.
Pala D; Scalvini L; Elisi GM; Lodola A; Mor M; Spadoni G; Ferrara FF; Pavoni E; Roscilli G; Milazzo FM; Battistuzzi G; Rivara S; Giannini G
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1685-1696. PubMed ID: 32907434
[TBL] [Abstract][Full Text] [Related]
2. Arylamidonaphtalene sulfonate compounds as a novel class of heparanase inhibitors.
Rondanin R; Fochi S; Baruchello R; Bernardi T; Oliva P; Semeraro F; Simoni D; Giannini G
Bioorg Med Chem Lett; 2017 Sep; 27(18):4421-4425. PubMed ID: 28811133
[TBL] [Abstract][Full Text] [Related]
3. Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design.
Zhou Z; Bates M; Madura JD
Proteins; 2006 Nov; 65(3):580-92. PubMed ID: 16972282
[TBL] [Abstract][Full Text] [Related]
4. Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity.
Messore A; Madia VN; Pescatori L; Saccoliti F; Tudino V; De Leo A; Bortolami M; De Vita D; Scipione L; Pepi F; Costi R; Rivara S; Scalvini L; Mor M; Ferrara FF; Pavoni E; Roscilli G; Cassinelli G; Milazzo FM; Battistuzzi G; Di Santo R; Giannini G
J Med Chem; 2018 Dec; 61(23):10834-10859. PubMed ID: 30412404
[TBL] [Abstract][Full Text] [Related]
5. Discovery of d-amino acid oxidase inhibitors based on virtual screening against the lid-open enzyme conformation.
Szilágyi B; Skok Ž; Rácz A; Frlan R; Ferenczy GG; Ilaš J; Keserű GM
Bioorg Med Chem Lett; 2018 Jun; 28(10):1693-1698. PubMed ID: 29699925
[TBL] [Abstract][Full Text] [Related]
6. Novel Benzazole Derivatives Endowed with Potent Antiheparanase Activity.
Madia VN; Messore A; Pescatori L; Saccoliti F; Tudino V; De Leo A; Bortolami M; Scipione L; Costi R; Rivara S; Scalvini L; Mor M; Ferrara FF; Pavoni E; Roscilli G; Cassinelli G; Milazzo FM; Battistuzzi G; Di Santo R; Giannini G
J Med Chem; 2018 Aug; 61(15):6918-6936. PubMed ID: 30010344
[TBL] [Abstract][Full Text] [Related]
7. Hit identification of novel heparanase inhibitors by structure- and ligand-based approaches.
Gozalbes R; Mosulén S; Ortí L; Rodríguez-Díaz J; Carbajo RJ; Melnyk P; Pineda-Lucena A
Bioorg Med Chem; 2013 Apr; 21(7):1944-51. PubMed ID: 23415087
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics: A rational combine approach used for the identification and in-vitro activity evaluation of potent β-Glucuronidase inhibitors.
Yousuf M; Shaikh NN; Ul-Haq Z; Choudhary MI
PLoS One; 2018; 13(12):e0200502. PubMed ID: 30517092
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.
Jia L; Ma S
Eur J Med Chem; 2016 Oct; 121():209-220. PubMed ID: 27240275
[TBL] [Abstract][Full Text] [Related]
10. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
[TBL] [Abstract][Full Text] [Related]
11. Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor.
Courtney SM; Hay PA; Buck RT; Colville CS; Phillips DJ; Scopes DI; Pollard FC; Page MJ; Bennett JM; Hircock ML; McKenzie EA; Bhaman M; Felix R; Stubberfield CR; Turner PR
Bioorg Med Chem Lett; 2005 May; 15(9):2295-9. PubMed ID: 15837312
[TBL] [Abstract][Full Text] [Related]
12. N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors.
Xu YJ; Miao HQ; Pan W; Navarro EC; Tonra JR; Mitelman S; Camara MM; Deevi DS; Kiselyov AS; Kussie P; Wong WC; Liu H
Bioorg Med Chem Lett; 2006 Jan; 16(2):404-8. PubMed ID: 16246551
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and β-glucuronidase inhibitory potential of benzimidazole derivatives.
Khan KM; Khan M; Ambreen N; Rahim F; Naureen S; Perveen S; Choudhary MI; Voelter W
Med Chem; 2012 May; 8(3):421-7. PubMed ID: 22530898
[TBL] [Abstract][Full Text] [Related]
14. Exploitation of heparanase inhibitors from microbial metabolites using an efficient visual screening system.
Ishida K; Teruya T; Simizu S; Osada H
J Antibiot (Tokyo); 2004 Feb; 57(2):136-42. PubMed ID: 15112962
[TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase.
Pala D; Rivara S; Mor M; Milazzo FM; Roscilli G; Pavoni E; Giannini G
Glycobiology; 2016 Jun; 26(6):640-54. PubMed ID: 26762172
[TBL] [Abstract][Full Text] [Related]
16. Development of heparanase inhibitors for anti-cancer therapy.
Miao HQ; Liu H; Navarro E; Kussie P; Zhu Z
Curr Med Chem; 2006; 13(18):2101-11. PubMed ID: 16918340
[TBL] [Abstract][Full Text] [Related]
17. 2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors.
Courtney SM; Hay PA; Buck RT; Colville CS; Porter DW; Scopes DI; Pollard FC; Page MJ; Bennett JM; Hircock ML; McKenzie EA; Stubberfield CR; Turner PR
Bioorg Med Chem Lett; 2004 Jun; 14(12):3269-73. PubMed ID: 15149688
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of heparanase inhibitors in cancer therapy.
Heyman B; Yang Y
Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
[TBL] [Abstract][Full Text] [Related]
19. Combined Ligand- and Receptor-Based Virtual Screening Methodology to Identify Structurally Diverse Protein Tyrosine Phosphatase 1B Inhibitors.
Gimeno A; Ardid-Ruiz A; Ojeda-Montes MJ; Tomás-Hernández S; Cereto-Massagué A; Beltrán-Debón R; Mulero M; Valls C; Aragonès G; Suárez M; Pujadas G; Garcia-Vallvé S
ChemMedChem; 2018 Sep; 13(18):1939-1948. PubMed ID: 30024103
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, radiolabeling with fluorine-18 and preliminary in vivo evaluation of a heparan sulphate mimetic as potent angiogenesis and heparanase inhibitor for cancer applications.
Kuhnast B; El Hadri A; Boisgard R; Hinnen F; Richard S; Caravano A; Nancy-Portebois V; Petitou M; Tavitian B; Dollé F
Org Biomol Chem; 2016 Feb; 14(6):1915-20. PubMed ID: 26757783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
